Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - COST OF REVENUE
Cost of Revenue VRDN - Viridian Therapeutics, Inc.
1.32 M
LAST VALUE
46.02%
2 YEAR CAGR
-46.59%
5 YEAR CAGR
-6.17%
10 YEAR CAGR